SEELOS THERAPEUTICS, INC.: going-concern / distress — Seelos Therapeutics files for Chapter 11 bankruptcy; stock moved to OTC Pink

SEELOS THERAPEUTICS, INC.

Filed voluntary Chapter 11 petition on November 15, 2024 in Southern District of New York.
Common stock moved from OTCQB to OTC Pink effective November 19, 2024 following bankruptcy.
Company intends to file Form 15 to suspend SEC reporting obligations immediately.
Securityholders warned they could experience significant or complete loss on investment.

Key facts

Extracted from this filing and checked against the source text.

Distress & Bankruptcy SEC 8-K Item 1.03 confidence 0.9

SEELOS THERAPEUTICS, INC. entered chapter 11 in United States Bankruptcy Court for the Southern District of New York (petition 2024-11-15).

Proceeding: chapter 11
Court: United States Bankruptcy Court for the Southern District of New York
Petition: 2024-11-15

Exact text from the filing

On November 15, 2024, Seelos Therapeutics, Inc. (the “ Company ”) filed a voluntary petition for relief (the “ Bankruptcy Petition ”) under chapter 11 of Title 11 of the United States Code (the “ Bankruptcy Code ”) in the United States Bankruptcy Court for the Southern District of New York

View on SEC.gov

Browse all distress & bankruptcy →

Source: SEC EDGAR

accession 0001099910-24-000383

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.